Innate Pharma (IDD.XETRA) Q1 2026 Earnings

26MarConfirmed
Q1 2025
Q3 2025
Q1 2026
-0.31
-0.28
-0.26
-0.24

Details

Expected EPS
-0.3052786392
Actual EPS
-0.3052786392
Surprise EPS
0
Surprise Percent
+0%

Description

Innate Pharma (IDD.XETRA) has reported earnings of -0.3052786392 per share for Q1 2026.

0 Comments

Share your thoughts